lisinopril and hydrochlorothiazide

Generic: lisinopril and hydrochlorothiazide

Labeler: qpharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lisinopril and hydrochlorothiazide
Generic Name lisinopril and hydrochlorothiazide
Labeler qpharma, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydrochlorothiazide 12.5 mg/1, lisinopril 10 mg/1

Manufacturer
QPharma, Inc.

Identifiers & Regulatory

Product NDC 42708-150
Product ID 42708-150_468261fd-e287-273c-e063-6294a90a7300
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077912
Listing Expiration 2026-12-31
Marketing Start 2006-10-04

Pharmacologic Class

Established (EPC)
thiazide diuretic [epc]
Chemical Structure
thiazides [cs]
Physiologic Effect
increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42708150
Hyphenated Format 42708-150

Supplemental Identifiers

RxCUI
197885
UNII
0J48LPH2TH E7199S1YWR
NUI
N0000175359 N0000175419 M0471776

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lisinopril and hydrochlorothiazide (source: ndc)
Generic Name lisinopril and hydrochlorothiazide (source: ndc)
Application Number ANDA077912 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
  • 10 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, PLASTIC (42708-150-30)
source: ndc

Packages (1)

Ingredients (2)

hydrochlorothiazide (12.5 mg/1) lisinopril (10 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "468261fd-e287-273c-e063-6294a90a7300", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "E7199S1YWR"], "rxcui": ["197885"], "spl_set_id": ["c80b2164-3795-6668-e053-2a95a90a4d45"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["QPharma, Inc."]}, "finished": true, "packaging": [{"sample": true, "description": "30 TABLET in 1 BOTTLE, PLASTIC (42708-150-30)", "package_ndc": "42708-150-30", "marketing_start_date": "20210730"}], "brand_name": "Lisinopril and Hydrochlorothiazide", "product_id": "42708-150_468261fd-e287-273c-e063-6294a90a7300", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "42708-150", "generic_name": "Lisinopril and Hydrochlorothiazide", "labeler_name": "QPharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisinopril and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "10 mg/1"}], "application_number": "ANDA077912", "marketing_category": "ANDA", "marketing_start_date": "20061004", "listing_expiration_date": "20261231"}